Illumina's Next Steps for Grail Divestiture

Some unanswered questions linger, but llumina executives recently shed some light onto its planned Grail divestiture.

After more than two years of figuratively duking it out with U.S. and European antitrust enforcers – not to mention taking heat from activist investor Carl Ichan – San Diego, CA-based Illumina conceded the fight for Grail in December. Last week, at the annual J.P. Morgan Healthcare Conference, Illumina's top executives shared a bit more color about the pending divestiture.